Showing results (291-300 of 468) with videos related to

Sort By:
Pageof 47
Journal of Clinical Pathology|December 21, 2010
Expression of heparan sulfate in gastric carcinoma and its correlation with clinicopathological features and patient survivalSoo-Ling Lo, Aye Aye Thike, Soo-Yong Tan, et al.
Pathology|February 13, 2018
An automated staining protocol for seven-colour immunofluorescence of human tissue sections for diagnostic and prognostic useJeffrey Chun Tatt Lim, Joe Poh Sheng Yeong, Chun Jye Lim, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Automated Renal Cancer Grading Using Nuclear Pleomorphic PatternsDaniel Aitor Holdbrook, Malay Singh, Yukti Choudhury, et al.
British Journal of Cancer|January 8, 2021
Multi-protein spatial signatures in ductal carcinoma in situ (DCIS) of breastSunil S Badve, Sanghee Cho, Yesim Gökmen-Polar, et al.
Breast Cancer Research : BCR|April 5, 2011
Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapyYvonne Hui-Fang Teng, Wai-Jin Tan, Aye-Aye Thike, et al.
Virchows Archiv : an International Journal of Pathology|May 18, 2026
Molecular characterization of mammary mucinous cystadenocarcinoma reveals recurrent TP53 and RB1 alterations with frequent PI3K-AKT pathway abnormalitiesWei-Yu Chen, Wan-Ching Chen, Puay Hoon Tan, et al.
Pathology|January 10, 2024
Predictive and prognostic biomarkers in urological tumoursAlessia Cimadamore, Carmine Franzese, Carla Di Loreto, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 20, 2008
Increased expression of non-sulfated chondroitin correlates with adverse clinicopathological parameters in prostate cancerYvonne Hui-Fang Teng, Puay-Hoon Tan, Sing-Joo Chia, et al.
Histopathology|January 3, 2014
Increased SOX2 expression in less differentiated breast carcinomas and their lymph node metastasesYu-Hua Huang, Ming-Hua Luo, Yun-Bi Ni, et al.
Breast Cancer Research and Treatment|October 26, 2021
KIF21A regulates breast cancer aggressiveness and is prognostic of patient survival and tumor recurrenceAnton J Lucanus, Aye Aye Thike, Xing Fei Tan, et al.
Pageof 47